Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (301-310 of 365) with videos related to

Pageof 37
Sort By:
Biochemical and Biophysical Research Communications|February 13, 2007
Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cellsYasuo Yoneyama, Yasuji Ueda, Yasunori Akutsu, et al.
Oncotarget|June 15, 2018
Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activityKuan Chai, Xuerao Ning, Thảo Thi Thanh Nguyễn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 21, 2015
A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cellsGuangyu Ma, Boya Zhong, Shinya Okamoto, et al.
Annals of Diagnostic Pathology|January 1, 2017
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesotheliomaDi Wu, Kenzo Hiroshima, Toshikazu Yusa, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Hepato-Gastroenterology|June 22, 2005
High en bloc resection rate achieved by endoscopic mucosal resection with IT knife for early gastric cancerShinichi Miyazaki, Yoshio Gunji, Taito Aoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Hepatic arterial infusion chemotherapy with oxaliplatin in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure]Masaru Tsuchiya, Masashi Watanabe, Junichi Koike, et al.
Cancer Science|June 1, 2006
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinomaHideaki Shimada, Hisahiro Matsubara, Tooru Shiratori, et al.
Diagnostic Cytopathology|April 16, 2016
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16Kenzo Hiroshima, Di Wu, Mizue Hasegawa, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 25, 2021
Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion ResearchNobuki Ishioka, Takashi Suzuki, Satoshi Yajima, et al.
Pageof 37

Showing results (301-310 of 365) with videos related to

Sort By:
Pageof 37
Biochemical and Biophysical Research Communications|February 13, 2007
Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cellsYasuo Yoneyama, Yasuji Ueda, Yasunori Akutsu, et al.
Oncotarget|June 15, 2018
Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activityKuan Chai, Xuerao Ning, Thảo Thi Thanh Nguyễn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 21, 2015
A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cellsGuangyu Ma, Boya Zhong, Shinya Okamoto, et al.
Annals of Diagnostic Pathology|January 1, 2017
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesotheliomaDi Wu, Kenzo Hiroshima, Toshikazu Yusa, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Hepato-Gastroenterology|June 22, 2005
High en bloc resection rate achieved by endoscopic mucosal resection with IT knife for early gastric cancerShinichi Miyazaki, Yoshio Gunji, Taito Aoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Hepatic arterial infusion chemotherapy with oxaliplatin in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure]Masaru Tsuchiya, Masashi Watanabe, Junichi Koike, et al.
Cancer Science|June 1, 2006
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinomaHideaki Shimada, Hisahiro Matsubara, Tooru Shiratori, et al.
Diagnostic Cytopathology|April 16, 2016
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16Kenzo Hiroshima, Di Wu, Mizue Hasegawa, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 25, 2021
Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion ResearchNobuki Ishioka, Takashi Suzuki, Satoshi Yajima, et al.
Pageof 37